Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Pancreas Stories

2009-02-25 11:26:15

Experimental technique safely differentiates patients with pancreatic cancer, precursor lesions and benign tumorsIn the latest clinical trial for a technique to detect pancreatic cancer, researchers found they could differentiate cells that are cancerous from those that are benign, pre-cancerous, or even early stage indicators called mucinous cystic lesions.Pancreatic cancer is dangerous to screen for, yet deadly if ignored. The pancreas is extremely sensitive--biopsies can lead to...

54124ad6321b19f40f67e228df30bf291
2008-12-22 10:20:00

Study boosts researchers' hopes of using osteocalcin to treat diabetes Rube Goldberg"”the cartoonist who devised complex machines for simple tasks"”would have smiled at one of leptin's mechanisms for curbing insulin release. As Hinoi et al. show, the fat-derived hormone enlists the sympathetic nervous system to prevent bone-making cells from releasing a molecule that prods the pancreas to discharge insulin. The study will appear online December 22, 2008 and in the December 29,...

2008-10-30 12:00:21

US-based pharmaceutical company Digestive Care has completed the submission of the new drug application for Pancrecarb, used in the treatment of exocrine pancreatic insufficiency, to the FDA. The FDA has previously granted the product fast track designation and approved a rolling new drug application (NDA) submission schedule. The company has recently announced results of the completed randomized, double-blind, placebo-controlled, multi-center, crossover study on Pancrecarb. Tibor...

2008-10-27 15:00:09

BETHLEHEM, Pa., Oct. 27 /PRNewswire/ -- Digestive Care, Inc. (DCI) announced today that it has completed the submission of the New Drug Application ("NDA") for PANCRECARB(R) (pancrelipase), used in the treatment of Exocrine Pancreatic Insufficiency ("EPI"), to the U.S. Food and Drug Administration ("FDA"). The FDA had previously granted the product Fast Track designation and approved a rolling NDA submission schedule. "Digestive Care has provided vital products used to improve the...

2008-08-30 09:00:20

By Chetty, Runjan * Context.-Although somewhat uncommon, neuroendocrine tumors of the gastrointestinal tract and pancreas have come under scrutiny in recent times. With advances in imaging techniques, more of these tumors are being removed and sent for pathologic evaluation. It is important for the diagnostic pathologist to be aware of recent developments in this field. Objective.-This overview focuses on nomenclature/terminology, classification, practical issues related to recent...

2008-08-20 00:00:14

Doctors in Houston are testing a procedure that transfers pancreatic cells into arms or legs to provide insulin for patients who have lost their pancreas. The work at Houston's Methodist Hospital builds on a small study in Sweden, the Houston Chronicle reports. A month ago, Wanda Prouty became the first person in the United States to undergo the procedure. In addition to preventing diabetes in people who have had the pancreas removed because of disease or injury, doctors say it might be...

2008-08-18 18:00:47

DEAR DR. DONOHUE: Twenty-five years ago I had a Whipple operation. My pancreas was removed. The doctor told me I had one year to live. Well, I outlived him. I have to take insulin and digestive pills, but other than that I have no other medicines, and I feel quite well. I'm better off than most of my friends. I just turned 84. How long do people usually live without a pancreas? - W.A. ANSWER: Dr. Whipple's original operation entailed removal of part of the stomach, a portion of the bile...

2008-08-01 06:00:46

Vitro Diagnostics, operating as Vitro Biopharma, has received approval for its preclinical diabetes study protocol. This approval allows the company to test its stem cell-derived human beta islets for effectiveness in reversing type I diabetes in well-established experimental models of the disease. Positive results from such studies are expected to further support various commercial applications of the company's stem cell-derived islets that are presently being developed for distribution...

2008-07-08 12:01:16

Digestive Care has submitted the first module of its new drug application for Pancrecarb, used in the treatment of exocrine pancreatic insufficiency, with the FDA. The FDA has granted the product fast track designation. In addition, Digestive Care has recently completed a randomized, double-blind, placebo-controlled, multi-center, crossover study on Pancrecarb MS-16. The clinical trial was conducted at five centers and included 21 subjects. Tibor Sipos, president and chief scientific...

2008-07-07 12:00:12

BETHLEHEM, Pa., July 7 /PRNewswire/ -- Digestive Care, Inc. (DCI) announced today that it has submitted the first module of its New Drug Application ("NDA") for PANCRECARB(R) (pancrelipase), used in the treatment of Exocrine Pancreatic Insufficiency ("EPI"), with the U.S. Food and Drug Administration ("FDA"). The FDA has granted the product Fast Track designation. "Digestive Care has provided vital products used to treat EPI for over a decade and we are committed to filing the remaining...


Latest Pancreas Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

More Articles (1 articles) »